SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02)
( SPRWYFYYL )
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in MHC ligand assays.
| Sequence: | SPRWYFYYL | |
| Gene: | N | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Nucleoprotein | |
| Species: | SARS-CoV-2 | |
| Allele: | HLA-B*07:02 | |
| Application : | Flow Cytometry | |
| Indication : | Coronavirus(COVID-19) | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€101.50*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS